Inactive

The TRICARE Pharmacy Services contract provides a pharmacy benefit to all eligible beneficiaries by providing state of the art technologies to enhance patient safety, efficiency, and costeffectiveness... The TRICARE Pharmacy Services contract provides a pharmacy benefit to all eligible beneficiaries by providing state of the art technologies to enhance patient safety, efficiency, and costeffectiveness. This program offers pharmacy services by (a) supporting direct care pharmacy at MTFs located at various military bases, (b) retail network pharmacies, authorized retail non-networks pharmacies, or (c) delivery through the Mail Order Pharmacies (MOP home delivery). This bridge action will provide a period of performance from November 1, 2022, through December 31, 2022 with two (2) 1-month options. The bridge action to extend performance is necessary to ensure continued support to the Defense Health Agency (DHA) by continuing to meet critical requirements, to prevent a gap in service of pharmacy benefits to all eligible beneficiaries from the end of the current TPharm4 contract on October 31, 2022 until the competitively awarded follow-on contract (TPharm5) full performance begins on January 1, 2023 and to ensure full performance of the new National Prime Vendor Pharmaceutical contract, awarded by the Defenses Logistics Agency (DLA).